STAT+: Pharmalittle: FDA declines to approve higher dose version of Regeneron eye drug; FDA warns wholesaler over counterfeit HIV pills

The FDA declined to approve a higher-dose version of a Regeneron Pharmaceuticals drug called Eylea.
Click here to view original post